NBY

NovaBay Pharmaceuticals Inc

This asset is no longer available for investment.

View all assets

Price

return (12m)

0.00%

p/e

-5.39

p/bv

0.23

DIVIDEND YIELD

330.58%

NBY price

NovaBay Pharmaceuticals Inc

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment NBY

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals NBY

Valuation

P/E

-5.39

Sector -2.23

Industry 0.52

P/BV

0.23

Sector 2.14

Industry 2.30

P/Revenue (PSR)

3.41

Sector 1.98

Industry 2.36

EV/EBITDA

Sector -24.41

Industry -19.03

EV/EBIT

Sector -37.37

Industry -19.09

P/EBITDA

-7.40

Sector -0.01

Industry 1.16

P/EBIT

-7.19

Sector -2.00

Industry -0.30

P/Total Assets

0.18

Sector 1.15

Industry 1.24

P/Ativo Circ. Liq.

Sector -10.54

Industry -12.34

P/Cap.Giro

Sector 0.02

Industry 3.10

EPS

-0.22

Sector -0.94

Industry -0.75

BVPS

5.34

Sector 3.93

Industry 4.90

Efficiency

Gross Margin

-0.87%

Sector 44.21%

Industry 49.44%

EBITDA Margin

Sector -312.85%

Industry -51.49%

EBIT Margin

-0.13%

Sector -193.57%

Industry -51.11%

Operating Margin

-58.93%

Sector -25.72%

Industry -28.72%

Net Profit Margins

-63.26%

Sector -30.17%

Industry -32.17%

Giro Ativos

0.01

Sector 0.12

Industry 0.14

Profitability

ROE

-4.21%

Sector -35.35%

Industry -37.91%

ROA

-3.25%

Sector -29.04%

Industry -27.45%

ROIC

Sector -439.00%

Industry -96.96%

Dividends

Dividend yield

330.58%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 1.87

Industry 1.94

Dívida Líquida/EBITDA

Sector -1.64

Industry -4.72

Dívida Líquida/EBIT

Sector -0.81

Industry -1.84

Dívida Líquida/Patrimônio

Sector -0.35

Industry -0.28

Dívida Bruta/Patrimônio

Sector 0.17

Industry 0.20

Equity/Assets

0.77

Sector 0.42

Industry 0.45

Liabilities/Assets

0.23

Sector 0.46

Industry 0.51

Growth

5Y Revenue CAGR

0.87%

Sector -

Industry -

5Y Earnings CAGR

-2.29%

Sector -

Industry -

Fundamentals NBY

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
NBY	-5.39	0.23	-4.21%	330.58%	$31.48 M	-63.26%
LLY	42.55	34.48	81.02%	0.54%	$1.08 T	34.99%
ISRG	38.26	6.56	17.15%	0.00%	$120.09 B	28.45%
SNY	7.10	1.26	17.79%	4.07%	$105.96 B	14.75%
NVS	23.21	7.06	30.41%	2.00%	$296.12 B	22.50%
TMO	29.78	3.93	13.19%	0.32%	$207.50 B	15.04%
ABT	25.64	3.09	12.06%	0.00%	$160.92 B	13.91%
MDT	22.18	2.13	9.59%	3.43%	$106.51 B	13.20%
GSK	13.15	4.44	33.77%	3.42%	$103.21 B	17.79%
CVS	46.73	1.76	3.78%	2.47%	$137.02 B	0.72%
BSX	18.64	2.57	13.78%	0.00%	$66.45 B	17.29%
TMDX	13.95	4.86	34.80%	0.00%	$2.40 B	27.04%
IDXX	39.73	27.96	70.38%	0.00%	$43.51 B	24.63%
RMD	18.74	4.39	23.41%	1.22%	$28.48 B	27.44%
HCA	12.70	-28.97	-228.14%	0.78%	$86.27 B	8.89%
DHR	33.74	2.57	7.61%	0.54%	$135.09 B	15.95%
SYK	37.64	5.47	14.52%	1.05%	$125.61 B	13.21%
PHG	22.19	1.90	8.56%	3.85%	$25.07 B	5.50%
COHR	117.65	5.01	4.26%	0.00%	$55.16 B	7.10%
INMD	11.06	1.46	13.18%	0.00%	$963.90 M	23.27%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NBY Historical Dividends

current DY: 330.58%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	09/29/2025	09/29/2025	4.00000000
Dividends	09/29/2025	09/29/2025	4.00000000
Dividends	09/29/2025	09/29/2025	4.00000000
Dividends	09/29/2025	09/29/2025	4.00000000
Dividends	09/29/2025	09/29/2025	4.00000000
Dividends	09/29/2025	09/29/2025	4.00000000
Dividends	09/29/2025	09/29/2025	4.00000000
Dividends	09/29/2025	09/29/2025	4.00000000

ABOUT NovaBay Pharmaceuticals Inc

NovaBay Pharmaceuticals Inc

Average Investor10 user rating

4.0 (6 people)

United States

- year

Founded:

Time since IPO - - year

-

Employees

NovaBay Pharmaceuticals Inc (United States) is listed on the Nasdaq and has a market capitalization of $31.48 million, with shareholders equity totaling $138.83 million.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, NovaBay Pharmaceuticals Inc reported $9.24 million in revenue, generating net income of $-5.84 million.

Key financial metrics include a P/E ratio of -5.39, a price-to-book (P/B) ratio of 0.23, and a trailing twelve-month dividend yield of 330.58%.

The company trades under the ticker NBY.

Market cap

$31.48 million

Net worth

$138.83 million

$138,825,000.00

Assets

$179.74 million

$179,743,000.00

Total Shares Outstanding

26.02 million

26,015,000

Average Daily Trading Volume

$554.45 Thousand

$554,450.00

Sector

Health

Industry

Pharmaceutical Products

NBY

NBY revenue and profits

Financial Results NBY

DRAG THE FRAME TO SEE MORE DATA

NBY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$107.74 85,09% (12M)

P/E

46.73

2.47%

ROE

3.78%

P/BV

1.76

CI - Cigna

$289.57 0,40% (12M)

P/E

11.72

2.13%

ROE

15.39%

P/BV

1.80

CNC - Centene

$63.41 123,35% (12M)

P/E

-4.85

0.00%

ROE

-29.93%

P/BV

1.45

HUM - Humana

$389.32 65,96% (12M)

P/E

41.90

0.67%

ROE

6.06%

P/BV

2.54

SNY - Sanofi

$43.35 --10,54% (12M)

P/E

7.10

4.07%

ROE

17.79%

P/BV

1.26

LLY - Eli Lilly

$1,196.03 49,27% (12M)

P/E

42.55

0.54%

ROE

81.02%

P/BV

34.48

HCA - HCA Healthcare

$382.19 15,07% (12M)

P/E

12.70

0.78%

ROE

-228.14%

P/BV

-28.97

NVS - Novartis

$155.01 34,26% (12M)

P/E

23.21

2.00%

ROE

30.41%

P/BV

7.06